Tag Archives: FACA

Assessing the Administrative Law Weaponry in the ‘War on Science,’ by Margaret Sova McCabe

by Guest Blogger — Friday, Oct. 27, 2017

Effective federal regulation has long been informed by scientific experts external to government. Since 1972, the Federal Advisory Committee Act (FACA) has operated to ensure that this external expertise is offered transparently and in a fair, balanced manner. The question explored in this post is whether our administrative law procedural safeguards are adequate to ensure […]

This entry was tagged .

FDA Advisory Committees and Industry-Funded Patient Advocacy

by Patti Zettler — Friday, June 23, 2017@pzettler

Cross-posted on Objective Intent and Stanford’s Law and the Biosciences Blog. Industry funding of patient advocacy organizations recently has received attention from media and researchers.  For example, one 2017 study in the New England Journal of Medicine found that over 80% of patient advocacy organizations with annual revenues of at least $7.5 million reported receiving industry […]